Ionis Pharmaceuticals, Inc.
MX ˙ BMV ˙ US4622221004
SecurityMX:IONS / Ionis Pharmaceuticals, Inc.
InstitutionHighTower Advisors, LLC
Latest Disclosed Ownership3,797 shares
Latest Disclosed Value $ 285,117
HighTower Advisors, LLC ownership in IONS / Ionis Pharmaceuticals, Inc.

On May 5, 2026 - HighTower Advisors, LLC filed a 13F-HR form disclosing ownership of 3,797 shares of Ionis Pharmaceuticals, Inc. (MX:IONS) valued at $285,117 USD as of March 31, 2026. The entity filed a previous 13F-HR on February 6, 2026 disclosing 5,122 shares of Ionis Pharmaceuticals, Inc.. This represents a change in shares of -25.87% during the quarter.

HighTower Advisors, LLC has a history of taking positions in derivatives of the underlying security (IONS) in the form of stock options. The firm currently holds call options representing 0 of underlying shares valued at $0 USD .

Note: prior versions of this page mistakenly stated that the share values represented the number of options, not the number of underlying shares. For more information on the data backing these reports, please see the SEC document Frequently Asked Questions About Form 13F.

Institutional Ownership: 13F and NPORT Filings

The Security and Class in the table below are shown exactly as filed by the investor. We do our best to track continuity of investments through acquisitions, and this will be reflected in the table as changes in names. In addition to descriptive data, performance of the investment is shown over time. To calculate quarterly performance, we first calculate cost basis of the shares purchased during the quarter, then use that to calculate gross profit. Quarterly return is Gross Profit / Starting Portfolio value.

Note that cost basis is calculated and stored in thousands, so small quarterly changes in shares frequently result in a cost basis of zero.

Upgrade to unlock premium data and export to Excel .

Institutional Put/Call Ratios
(Premium Subscription Required)

In addition to reporting standard equity and debt issues, institutions with more than 100MM assets under management must also disclose their put and call option holdings. Since put options generally indicate negative sentiment, and call options indicate positive sentiment, we can get a sense of the overall institutional sentiment by plotting the ratio of puts to calls. The chart to the right plots the historical put/call ratio for this instrument.

Using Put/Call Ratio as an indicator of investor sentiment overcomes one of the key deficiencies of using total institutional ownership, which is that a significant amount of assets under management are invested passively to track indices. Passively-managed funds do not typically buy options, so the put/call ratio indicator more closely tracks the sentiment of actively-managed funds.

MX:IONS / Ionis Pharmaceuticals, Inc. Historical Put/Call Ratio
Disclosed Equity Positions (from 13F/NPORT Filings)
File
Date
Effective
Date
Form Security Class ID Avg Price
Paid (Est)
Reported
Shares
ΔShares ΔShares
(%)
Reported
Value
(x1000)
ΔValue
(%)
Alloc
(%)
ΔAlloc ΔAlloc (%) Cost Basis
(x1000)
Unrealized
Gain/Loss
(x1000)
2026-05-05 2026-03-31 13F IONIS PHARMACEUTICALS COM 462222100 3,797 -1,325 -25.87 285 -29.63 0.0003
2026-02-06 2025-12-31 13F IONIS PHARMACEUTICALS COM 462222100 5,122 -336 -6.16 405 13.45 0.0004
2025-11-07 2025-09-30 13F IONIS PHARMACEUTICALS COM 462222100 5,458 101 1.89 357 69.19 0.0004
2025-08-11 2025-06-30 13F IONIS PHARMACEUTICALS COM 462222100 5,357 5,357 212 0.0003
2025-02-07 2024-12-31 13F IONIS PHARMACEUTICALS COM 462222100 0 -5,559 -100.00 0 -100.00
2024-11-14 2024-09-30 13F IONIS PHARMACEUTICALS COM 462222100 5,559 -75 -1.33 223 -17.71 0.0003
2024-08-13 2024-06-30 13F IONIS PHARMACEUTICALS COM 462222100 5,634 549 10.80 271 22.62 0.0004
2024-05-06 2024-03-31 13F IONIS PHARMACEUTICALS COM 462222100 5,085 -6,001 -54.13 221 -60.54 0.0004
2024-02-12 2023-12-31 13F IONIS PHARMACEUTICALS COM 462222100 11,086 -18 -0.16 560 10.67 0.0009
2023-11-08 2023-09-30 13F IONIS PHARMACEUTICALS COM 462222100 11,104 -145 -1.29 506 9.76 0.0010
2023-08-14 2023-06-30 13F IONIS PHARMACEUTICALS COM 462222100 11,249 -220 -1.92 461 12.71 0.0009
2023-05-12 2023-03-31 13F IONIS PHARMACEUTICALS COM 462222100 11,469 303 2.71 409 -2.85 0.0009
2023-02-09 2022-12-31 13F IONIS PHARMACEUTICALS COM 462222100 11,166 2,301 25.96 421 7.12 0.0010
2022-11-09 2022-09-30 13F IONIS PHARMACEUTICALS COM 462222100 8,865 -623 -6.57 393 12.61 0.0011
2022-08-10 2022-06-30 13F IONIS PHARMACEUTICALS COM 462222100 9,488 376 4.13 349 3.87 0.0009
2022-05-12 2022-03-31 13F IONIS PHARMACEUTICALS COM 462222100 9,112 -18,026 -66.42 336 -59.32 0.0007
2022-02-10 2021-12-31 13F IONIS PHARMACEUTICALS COM 462222100 27,138 17,281 175.32 826 147.31 0.0018
2021-11-12 2021-09-30 13F IONIS PHARMACEUTICALS COM 462222100 9,857 554 5.96 334 -8.74 0.0009
2021-08-06 2021-06-30 13F IONIS PHARMACEUTICALS COM 462222100 9,303 -216 -2.27 366 -14.08 0.0011
2021-05-10 2021-03-31 13F IONIS PHARMACEUTICALS COM 462222100 9,519 -5,563 -36.89 426 -50.12 0.0013
2021-02-10 2020-12-31 13F IONIS PHARMACEUTICALS COM 462222100 15,082 3,120 26.08 854 51.42 0.0036
2020-11-13 2020-09-30 13F IONIS PHARMACEUTICALS COM 462222100 11,962 -76 -0.63 564 -19.77 0.0027
2020-08-10 2020-06-30 13F IONIS PHARMACEUTICALS COM 462222100 12,038 -140 -1.15 703 23.33 0.0038
2020-05-21 2020-03-31 13F IONIS PHARMACEUTICALS COM 462222100 12,178 289 2.43 570 -20.50 0.0037
2020-02-14 2019-12-31 13F IONIS PHARMACEUTICALS COM 462222100 11,889 -117 -0.97 717 0.28 0.0042
2019-11-12 2019-09-30 13F IONIS PHARMACEUTICALS COM 462222100 12,006 -197 -1.61 715 -9.38 0.0039
2019-08-13 2019-06-30 13F IONIS PHARMACEUTICALS COM 462222100 12,203 3,380 38.31 789 10.35 0.0047
2019-05-15 2019-03-31 13F IONIS PHARMACEUTICALS COM 462222100 8,823 -10,054 -53.26 715 -30.11 0.0048
2019-02-14 2018-12-31 13F IONIS PHARMACEUTICALS COM 462222100 18,877 10,245 118.69 1,023 127.84 0.0078
2018-11-09 2018-09-30 13F IONIS PHARMACEUTICALS COM 462222100 8,632 -139 -1.58 449 21.02 0.0032
2018-08-14 2018-06-30 13F IONIS PHARMACEUTICALS COM 462222100 8,771 -748 -7.86 371 -11.88 0.0029
2018-05-15 2018-03-31 13F IONIS PHARMACEUTICALS COM 462222100 9,519 -451 -4.52 421 -16.80 0.0035
2018-02-14 2017-12-31 13F IONIS PHARMACEUTICALS COM 462222100 9,970 -690 -6.47 506 -7.16 0.0042
2017-11-14 2017-09-30 13F IONIS PHARMACEUTICALS COM 462222100 10,660 1,001 10.36 545 9.88 0.0046
2017-09-22 2017-06-30 13F/A-1 IONIS PHARMACEUTICALS COM 462222100 9,659 -1,580 -14.06 496 10.47 0.0044
2017-08-14 2017-06-30 13F IONIS PHARMACEUTICALS COM 462222100 9,659 -1,580 496
2017-05-15 2017-03-31 13F IONIS PHARMACEUTICALS COM 462222100 11,239 3,076 37.68 449 14.54 0.0043
2017-02-10 2016-12-31 13F IONIS PHARMACEUTICALS COM 462222100 8,163 -5,906 -41.98 392 -23.29 0.0043
2016-11-14 2016-09-30 13F IONIS PHARMACEUTICALS COM 462222100 14,069 14,069 0.00 511 0.0059
2016-08-11 2016-06-30 13F IONIS PHARMACEUTICALS COM 462222100 0 -23,718 -100.00 0 -100.00
2016-05-16 2016-03-31 13F IONIS PHARMACEUTICALS COM 462222100 23,718 1,589 7.18 954 -30.21 0.0031
2016-05-18 2015-12-31 13F/A-1 IONIS PHARMACEUTICALS COM 462222100 22,129 15,702 244.31 1,367 433.98 0.0162
2016-02-12 2015-12-31 13F IONIS PHARMACEUTICALS COM 462222100 22,129 1,367
2015-11-16 2015-09-30 13F ISIS PHARMACEUTICALS COM 464330109 6,427 2,451 61.64 256 12.28 0.0034
2015-08-11 2015-06-30 13F ISIS PHARMACEUTICALS COM 464330109 3,976 3,976 228 0.0037
Disclosed Call Options
File
Date
Effective
Date
Form Security Class ID Opt Avg Share
Price
Shares ΔShares
(%)
Value
(x1000)
ΔValue
(%)
Prior Allocation
(%)
Allocation
(%)
ΔAllocation
(%)
Cost Basis
(x1000)
Profit
(x1000)
Return
(%)
2018-05-15 2018-03-31 13F IONIS PHARMACEUTICALS COM Call 0 -100.00 0 n/a n/a n/a
2018-02-14 2017-12-31 13F IONIS PHARMACEUTICALS COM Call 500 0 n/a n/a n/a
Legend
Shares
The total number of shares held by the institution at the end of the reporting period (the effective date). This is provided in the filing.
Value
The total value of the shares as of the effective date. This is provided in the filing.
Avg. Share Price
The weighted average share price of the shares held by the institution. We use FIFO accounting to determine this price
Class
This is the security class as indicated by the filer. There are a variety of values for this field. Common values include "EC" = equity common, "EP" - equity preferred
Allocation (%)
The percent of the institution's portfolio that this position represents. This is provided in NPORT filings. For 13F filings, we calculate it.
Change in Allocation
The change in allocation from the prior reporting period. This is calculated as current allocation - prior allocation.
Change in Allocation (%)
The percent change in allocation from the prior reporting period. This is calculated as (current allocation - prior allocation) / prior allocation.
Cost Basis
The total cost of the shares held. This is calculated as reported shares * avg. share price
Unrealized Gain/Loss
This is the market value of the position as of the effective date minus the cost basis.